Trial Profile
Pilot Study: Assessing Near Infrared Fluorescence Imaging Medical Technology for the Detection of Bladder Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Bladder cancer
- Focus Diagnostic use
- 26 Jul 2018 Status changed from recruiting to completed.
- 28 Nov 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2018.
- 28 Nov 2017 Status changed from not yet recruiting to recruiting.